
KNW
USDKnow Labs Inc. Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$3.360
High
$3.490
Low
$2.500
Volume
0.82M
Company Fundamentals
Market Cap
20.2M
Industry
Scientific & Technical Instruments
Country
United States
Trading Stats
Avg Volume
5.83M
Exchange
ASE
Currency
USD
52-Week Range
AI Analysis Report
Last updated: Jul 13, 2025KNW (Know Labs Inc. Common Stock): Unpacking Recent Shifts and Future Signals
Stock Symbol: KNW Generate Date: 2025-07-13 12:52:16
Let's break down what's been happening with Know Labs and what the data might be telling us.
Recent News Buzz
The news flow for Know Labs has been quite interesting, carrying a bit of a mixed bag. On one hand, we saw a significant announcement on June 6th: Greg Kidd, a notable figure, is set to acquire a controlling interest in Know Labs. Not only that, but he's also planning to introduce a Bitcoin treasury strategy for the company. This is a pretty big deal. It suggests a new strategic direction and potentially a strong vote of confidence from a new major investor. For a company focused on non-invasive health monitoring, bringing in a Bitcoin treasury strategy is certainly unconventional and could attract a lot of attention, both positive and negative.
Then, just a few days later, on June 10th, news surfaced about a shareholder alert from a class action firm investigating a merger involving KNW. While the details here are sparse, and it mentions other companies (HLGN, PVBC) alongside KNW, the very mention of a "class action firm investigating a merger" can often cast a shadow. It raises questions, even if it's just a preliminary investigation. So, you have this exciting new investor and Bitcoin strategy announcement, immediately followed by a legal firm sniffing around. That's definitely a mixed signal for investors to chew on.
Price Check: What the Stock's Been Doing
Looking at the past 30 days, KNW's stock has been on quite a ride. Before early June, the price hovered in the $0.40 to $0.50 range, showing relatively stable, albeit low, activity. But then, things exploded. On June 6th, the very day of the Greg Kidd announcement, the stock shot up dramatically, from around $0.54 to closing at $1.03, with massive volume. This surge continued, peaking around $4.43 on June 12th. That's a huge jump, clearly driven by the news.
After that initial spike, the price pulled back, settling into a range mostly between $1.50 and $4.00 through late June and early July. More recently, the stock has shown some renewed strength, climbing from lows around $1.59 on June 27th to $3.33 on July 11th. This suggests that after the initial excitement and subsequent correction, there's still some underlying positive momentum.
Now, let's compare this to the AI's predictions. The AI model from AIPredictStock.com suggests a flat day today (0.00% change), followed by modest gains: 1.22% tomorrow and 2.49% the day after. These predictions, while not massive, point to a continued upward lean in the very short term, aligning with the recent recovery we've seen in the price action.
Outlook & Ideas
Putting it all together, the situation for KNW appears to lean cautiously positive in the near term, especially given the recent price recovery and the AI's gentle upward predictions. The Greg Kidd investment and the Bitcoin treasury strategy are significant catalysts that have clearly energized the stock, despite the class action firm's investigation. The market seems to be focusing more on the potential upside from the new strategic direction.
Potential Entry Consideration: Given the current price of $3.33 (as of July 11th's close) and the AI's prediction of continued, albeit small, gains, an entry around the current price, perhaps on any slight dip towards the $3.20 to $3.33 range, might be considered. This range aligns with recent support levels and the AI's indication of a strong buying opportunity near $3.25. It seems the market is digesting the big news and finding a new, higher baseline.
Potential Exit/Stop-Loss Consideration: For managing risk, a stop-loss level around $2.98 could be a sensible point. This is just below recent lows and the suggested support level, acting as a clear signal to cut losses if the positive momentum falters significantly. On the upside, if the stock continues its climb, a take-profit target around $4.13 could be considered. This aligns with the AI's projected upward trend and could represent a logical point to lock in gains if the stock approaches its recent highs.
Company Context
It's important to remember that Know Labs is a relatively small company, with a market cap of about $25 million and only 6 full-time employees. They specialize in non-invasive health monitoring solutions. This means that while the new investment and Bitcoin strategy are exciting, the company's core business in a specialized tech sector is still the long-term driver. The high volatility and small market capitalization are key risk factors to keep in mind. Any news, good or bad, can have a magnified effect on such a company's stock price. The P/E ratio being negative (-14.47x) is common for growth-focused tech companies that are still in development phases, but the AI's note about it being "significantly below industry average" suggests a potential value play within its sector.
Disclaimer: This analysis is for informational purposes only and should not be considered financial advice. Investing in stocks involves risks, and you could lose money. Always conduct your own thorough research and consult with a qualified financial advisor before making any investment decisions. The predictions and recommendations provided are based on an AI model and historical data, and actual results may vary significantly.
Related News
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger: HLGN, KNW and PVBC
Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for...
Greg Kidd to Acquire Controlling Interest in Know Labs and Introduce Bitcoin Treasury Strategy
Know Labs, Inc. (NYSE American: KNW ("Know Labs" or the "Company"), a technology innovator specializing in non-invasive health monitoring solutions, today announced that it has entered into an agreement with Goldeneye
AI PredictionBeta
AI Recommendation
Updated at: Jul 15, 2025, 12:46 PM
62.2% Confidence
Risk & Trading
Entry Point
$2.62
Take Profit
$3.34
Stop Loss
$2.42
Key Factors
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.